Cancer BiologyClinical Cancer ResearchPeer-reviewed
Author
Cynthia J. Clendenin
University of PennsylvaniaORCID 0000-0003-4535-2088Unclaimed ORCID profile · follow to get notified of new preprints
Biology Disciplines
Click to filter author papersSignature Assays, Organisms & Methods
Click to filter · or open tagActivity by Year
2024-2025 · peak 3/yrCo-Author Collaboration Network
10 top collaborators · 39 mutual co-author linksFocal author (center)Selected co-authorORCID co-authorUnlinked name
Curved chords = mutual co-authorship4 papers
Recent·Most cited
- Cancer BiologybioRxivPreprint
Effect of Stroma-directed Drugs in Combination with Chemotherapy Against Pancreatic Cancer- a Preclinical Study
Mamta Gupta, Hoon Choi, Emma Elizabeth Furth…·Rong Zhou
This study compares chemotherapy with and without stroma-directed drugs in a mouse model of pancreatic cancer, finding enhanced tumor growth inhibition and changes in tumor microenvironment.
- BioinformaticsCell Reports MedicinePeer-reviewed
Cytometry Masked Autoencoder: An Accurate and Interpretable Automated Immunophenotyper
Jaesik Kim, Matei Ionita, Matthew Lee…·Dokyoon Kim
The paper introduces cyMAE, a masked autoencoder for automated immunophenotyping, showing it improves accuracy and interpretability over manual methods in cytometry data analysis.
9 citations - Cancer BiologyNaturePeer-reviewed
Tumor-selective effects of active RAS inhibition in pancreatic ductal adenocarcinoma
Urszula N. Wasko, Jingjing Jiang, Tanner C. Dalton…·Kenneth P. Olive
This study evaluates the therapeutic potential of RMC-7977, a broad-spectrum RAS inhibitor, in pancreatic ductal adenocarcinoma models, showing strong anti-tumor effects with minimal impact on normal tissues.